MRNA Oct 2024 120.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

20.70

-0.95

(-4.39%)

As of 12:18PM EDT. Market open.

Loading interactive chart…

Investor's Business Daily
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Moderna is on the rise after the Food and Drug Administration delayed a decision on its RSV vaccine. But is MRNA stock, once again, a buy?
Zacks
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Moderna's (MRNA) RSV vaccine, mRNA-1345's review timeline gets delayed. A decision is now expected by the end of May.
Simply Wall St.
While shareholders of Moderna (NASDAQ:MRNA) are in the black over 5 years, those who bought a week ago aren't so fortunate
Long term investing can be life changing when you buy and hold the truly great businesses. And we've seen some truly...